Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021
Corporate Participants:
Mike Hencke — Director, Investor Relations
Michel Vounatsos — Chief Executive Officer
Alfred W. Sandrock — Executive Vice President
Michael McDonnell — Executive Vice President Chief Financial Officer
Analysts:
Max Skor — Morgan Stanley — Analyst
Terence Flynn — Goldman Sachs — Analyst
Marc Goodman — SVB Leerink — Analyst
Umer Raffat — Evercore — Analyst
Cory Kasimov — JPMorgan — Analyst
Evan Seigerman — Credit Suisse — Analyst
Michael Yee — Jefferies — Analyst
Paul Matteis — Stifel — Analyst
Phil Nadeau — Cowen & Company — Analyst
Jay Olson — Oppenheimer — Analyst
Robyn Karnauskas — Truist — Analyst
Salim Syed — Mizuho — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
BLK Q4 Preview: BlackRock appears poised for another earnings beat
BlackRock, Inc. (NYSE: BLK), the largest asset management company, is set to publish its fourth-quarter 2025 results next week. The update is expected to shed light on how the firm’s
A look at Best Buy’s (BBY) progress on its growth strategy
Shares of Best Buy Co., Inc. (NYSE: BBY) fell over 3% on Wednesday. The stock has dropped 17% over the past 12 months. The consumer electronics retailer delivered sales and
